0001144204-17-017213.txt : 20170329 0001144204-17-017213.hdr.sgml : 20170329 20170329131243 ACCESSION NUMBER: 0001144204-17-017213 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20170329 DATE AS OF CHANGE: 20170329 EFFECTIVENESS DATE: 20170329 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Epica International, Inc. CENTRAL INDEX KEY: 0001627509 IRS NUMBER: 464501815 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-260325 FILM NUMBER: 17721575 BUSINESS ADDRESS: STREET 1: 2753 CAMINO CAPISTRANO STREET 2: SUITE A-101 CITY: SAN CLEMENTE STATE: CA ZIP: 92672 BUSINESS PHONE: 9492386323 MAIL ADDRESS: STREET 1: 2753 CAMINO CAPISTRANO STREET 2: SUITE A-101 CITY: SAN CLEMENTE STATE: CA ZIP: 92672 D/A 1 primary_doc.xml X0707 D/A LIVE 0001627509 Epica International, Inc. 2753 CAMINO CAPISTRANO SUITE A-101 SAN CLEMENTE CA CALIFORNIA 92672 9492386323 NEVADA None None Corporation true 2013 Gregory Stoutenburgh 2753 Camino Capistrano, Suite A-101 San Clemente CA CALIFORNIA 92672 Executive Officer Director Chief Executive Officer and Chairman Damiano Fortuna 2753 Camino Capistrano, Suite A-101 San Clemente CA CALIFORNIA 92672 Director Eric Lindquist 2753 Camino Capistrano, Suite A-101 San Clemente CA CALIFORNIA 92672 Executive Officer Director Chief Medical Officer Philip Warth 2753 Camino Capistrano, Suite A-101 San Clemente CA CALIFORNIA 92672 Director Michael Fajardo 2753 Camino Capistrano, Suite A-101 San Clemente CA CALIFORNIA 92672 Executive Officer Director Chief Financial Officer Renzo Valleggi 2753 Camino Capistrano, Suite A-101 San Clemente CA CALIFORNIA 92672 Executive Officer Director Chief Technology Officer Thomas Grossman 2753 Camino Capistrano, Suite A-101 San Clemente CA CALIFORNIA 92672 Director Jerry Sherlock 2753 Camino Capistrano, Suite A-101 San Clemente CA CALIFORNIA 92672 Executive Officer Chief Operations Officer Other Health Care Decline to Disclose 06b true 0001144204-16-091531 2016-03-21 false true false 9999 PHX Financial, Inc. 144403 None None 100 WALL STREET, 10TH FLOOR NEW YORK NY NEW YORK 10005 All States false 3000000 726077 2273923 The offering closed on August 10, 2016. false 3 390000 true 0 PHX will receive a cash commission and a non-accountable expense equal to 10% and 3%, respectively, of the aggregate gross proceeds. PHX will also receive warrants to purchase shares of common stock equal to 10% of the total number of shares issued. 0 false Epica International, Inc. /s/ Gregory Stoutenburgh Gregory Stoutenburgh CEO and Chairman 2016-03-30